These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

123 related articles for article (PubMed ID: 90270)

  • 1. A glycoside-hydrolase inhibitor in treatment of dumping syndrome.
    McLoughlin JC; Buchanan KD; Alam MJ
    Lancet; 1979 Sep; 2(8143):603-5. PubMed ID: 90270
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Combined use of guar and acarbose in reduction of postprandial glycaemia.
    Jenkins DJ; Taylor RH; Nineham R; Goff DV; Bloom SR; Sarson D; Alberti KG
    Lancet; 1979 Nov; 2(8149):924-7. PubMed ID: 91023
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Response of serum levels of gastric inhibitory polypeptide and insulin to sucrose ingestion during long-term application of acarbose.
    Fölsch UR; Ebert R; Creutzfeldt W
    Scand J Gastroenterol; 1981; 16(5):629-32. PubMed ID: 7034156
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Effect of acarbose on biochemical responses and clinical symptoms in dumping syndrome.
    Lyons TJ; McLoughlin JC; Shaw C; Buchanan KD
    Digestion; 1985; 31(2-3):89-96. PubMed ID: 3888753
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Improved metabolic profiles in insulin-treated diabetic patients given an alpha-glucosidehydrolase inhibitor.
    Walton RJ; Sherif IT; Noy GA; Alberti KG
    Br Med J; 1979 Jan; 1(6158):220-1. PubMed ID: 369651
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effect of the alpha-glucosidase-inhibitor BAY-g-5421 on blood glucose control of sulphonylurea-treated diabetics and insulin-treated diabetics.
    Sachse G; Willms B
    Diabetologia; 1979 Nov; 17(5):287-90. PubMed ID: 387504
    [No Abstract]   [Full Text] [Related]  

  • 7. Therapeutic potential of alpha-glucosidase-inhibitors.
    Fölsch UR
    Hepatogastroenterology; 1982 Apr; 29(2):47-8. PubMed ID: 7044933
    [No Abstract]   [Full Text] [Related]  

  • 8. [Acarbose--a new therapeutic principle in diabetes mellitus therapy].
    Schöffling K; Hillebrand I
    Dtsch Med Wochenschr; 1981 Aug; 106(35):1083-4. PubMed ID: 6114844
    [No Abstract]   [Full Text] [Related]  

  • 9. The effects of an alpha-glucoside hydrolase inhibitor on glycemia and the absorption of sucrose in man determined using a tracer method.
    Radziuk J; Kemmer F; Morishima T; Berchtold P; Vranic M
    Diabetes; 1984 Mar; 33(3):207-13. PubMed ID: 6365657
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Scope and specificity of acarbose in slowing carbohydrate absorption in man.
    Jenkins DJ; Taylor RH; Goff DV; Fielden H; Misiewicz JJ; Sarson DL; Bloom SR; Alberti KG
    Diabetes; 1981 Nov; 30(11):951-4. PubMed ID: 7028548
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Efficacy of octreotide acetate in treatment of severe postgastrectomy dumping syndrome.
    Geer RJ; Richards WO; O'Dorisio TM; Woltering EO; Williams S; Rice D; Abumrad NN
    Ann Surg; 1990 Dec; 212(6):678-87. PubMed ID: 2256759
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Delayed gastric emptying occurs following acarbose administration and is a further mechanism for its anti-hyperglycaemic effect.
    Ranganath L; Norris F; Morgan L; Wright J; Marks V
    Diabet Med; 1998 Feb; 15(2):120-4. PubMed ID: 9507911
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Long-term effect of alpha-glucosidase inhibitor on late dumping syndrome.
    Hasegawa T; Yoneda M; Nakamura K; Ohnishi K; Harada H; Kyouda T; Yoshida Y; Makino I
    J Gastroenterol Hepatol; 1998 Dec; 13(12):1201-6. PubMed ID: 9918426
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The effect of alpha-glucosidase inhibitor on burning epigastralgia in dumping syndrome: a case report].
    Mimura M; Tsukakubo T; Tsujiguchi N; Hoshikawa T
    Masui; 1996 Mar; 45(3):337-9. PubMed ID: 8721135
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Effect of pectin on gastric emptying and gut hormone release in the dumping syndrome.
    Lawaetz O; Blackburn AM; Bloom SR; Aritas Y; Ralphs DN
    Scand J Gastroenterol; 1983 May; 18(3):327-36. PubMed ID: 6369514
    [TBL] [Abstract][Full Text] [Related]  

  • 16. [Effect of acarbose in non-insulin dependent diabetes mellitus with dumping syndrome after gastrectomy].
    Hasegawa T; Makino I
    Nihon Shokakibyo Gakkai Zasshi; 1995 Mar; 92(3):267. PubMed ID: 7731101
    [No Abstract]   [Full Text] [Related]  

  • 17. Improvement of metabolic control in insulin dependent diabetics treated with the alpha-glucosidase inhibitor acarbose for two months.
    Gérard J; Luyckx AS; Lefebvre PJ
    Diabetologia; 1981 Nov; 21(5):446-51. PubMed ID: 7028558
    [TBL] [Abstract][Full Text] [Related]  

  • 18. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on postprandial blood glucose, serum insulin, and triglyceride levels: dose-time-response relationships in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):87-94. PubMed ID: 375343
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Acarbose in reactive hypoglycemia: a double-blind study.
    Gérard J; Luyckx AS; Lefèbvre PJ
    Int J Clin Pharmacol Ther Toxicol; 1984 Jan; 22(1):25-31. PubMed ID: 6698657
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effects of the alpha-glucosidase inhibitor BAY g 5421 (Acarbose) on meal-stimulated elevations of circulating glucose, insulin, and triglyceride levels in man.
    Hillebrand I; Boehme K; Frank G; Fink H; Berchtold P
    Res Exp Med (Berl); 1979 Apr; 175(1):81-6. PubMed ID: 375342
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.